201731-19-3 Usage
Uses
Used in Biological Research:
5-Cholesten-3-ol 6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproate is used as a fluorescently-tagged cholesterol derivative for studying its interactions with proteins, cellular utilization, and liposome formation. The fluorescent tag enables researchers to track and analyze the behavior of cholesterol in biological membranes more effectively.
Used in Drug Delivery Systems:
In the pharmaceutical industry, 5-cholesten-3-ol 6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproate can be used as a component in the development of drug delivery systems, particularly for targeting and imaging specific cellular processes involving cholesterol.
Used in Assay Development:
5-Cholesten-3-ol 6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproate is used as a key component in the development of assays for lipid metabolism, allowing researchers to study the metabolic pathways and regulatory mechanisms involving cholesterol in cells.
Used in Diagnostic Applications:
In the medical field, 5-cholesten-3-ol 6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproate can be employed as a diagnostic tool to visualize and analyze cholesterol distribution in cells and tissues, aiding in the detection and monitoring of various cholesterol-related conditions.
Used in Membrane Biophysics:
In the field of biophysics, 5-cholesten-3-ol 6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproate is used as a model compound to study the structural and dynamic properties of membrane bilayers, contributing to a better understanding of the role of cholesterol in cellular processes.
Check Digit Verification of cas no
The CAS Registry Mumber 201731-19-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,1,7,3 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 201731-19:
(8*2)+(7*0)+(6*1)+(5*7)+(4*3)+(3*1)+(2*1)+(1*9)=83
83 % 10 = 3
So 201731-19-3 is a valid CAS Registry Number.